Volume 10, Number 7—July 2004
Research
Molecular Analysis of Plasmodium ovale Variants
Table 2
Position |
444 |
471 |
501 |
552 |
599 |
600 |
633 |
685 |
700 |
720 |
774 |
786 |
789 |
860 |
881 |
886 |
895 |
896 |
914 |
Nigerian I/CDC | T | T | T | A | A | A | T | A | C | G | T | A | T | C | A | C | A | G | A |
Classic isolate | T | T | T | A | A | A | T | A | G | G | T | A | T | C | A | C | A | G | A |
(P→A) | |||||||||||||||||||
Variant isolate | C | C | G | G | G | G | C | G | G | T | A | C | C | A | G | G | G | C | C |
(K→R) | (N→D) | (P→A) | (T→K) | (K→R) | (H→D) | (S→A) | (E→A) |
aNucleotide numbers in boldface indicate positions resulting in nonsilent mutations (parentheses).
Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.